On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The new online Learning Center with new content can still be found under the “Training” folder on ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...